COX-2、CDKN2A在慢性乙型肝炎、肝硬化肝组织中的表达及意义

高保华; 刘冰; 郑建云; 吴方雄; 汪雯; 李雷; 牛春燕

COX-2、CDKN2A在慢性乙型肝炎、肝硬化肝组织中的表达及意义

1. 西安医学院附属医院消化内科
2. 西安医学院附属医院病理科

详细信息

中图分类号: R512.62
计量
- 文章访问数: 4389
- HTML全文浏览量: 13
- PDF下载量: 981
- 被引次数: 0
出版历程
- 出版日期: 2011-03-20

The study of the expression of COX-2 and CDKN2A in chronic hepatitis B and liver cirrhosis

摘要

摘要: 目的了解慢性乙型肝炎（CHB）、肝硬化肝组织中COX-2、CDKN2A的表达及其与肝脏损伤程度的关系。方法经免疫学及肝穿刺病理学证实为CHB患者46例、乙型肝炎肝硬化17例;正常肝组织10例（来自肝脏良性肿瘤手术切除的标本）。应用病理学判断肝组织的炎症及纤维化程度。采用免疫组化方法、半定量逆转录聚合酶链反应（RT-PCR）和免疫印迹分析法检测COX-2、CDKN2A在组织中的表达。结果（1）CDKN2A mRNA第一、第二外显子在正常肝、CHB及肝硬化组织的表达水平及CDKN2A蛋白的半定量分析差异有统计学意义（F=28.75、24.86、26.43,P=0.036、0.041、0.038）。（2）正常肝、CHB及肝硬化组织中的COX-2、CDKN2A蛋白水平的表达差异有统计学意义（χ2=13.48、15.73,P=0.042、0.021）;肝组织炎症不同级别的COX-2、CDKN2A蛋白水平的表达差异具有统计学意义（χ2=22.45、23.67,P=0.038、0.027）;肝组织纤维化不同程度的COX-2、CDKN2A蛋白水平的表达差异具有统计学意义（χ2=24.16、22.53...
- 环氧化酶2 /
- 周期素依赖激酶抑制剂p16 /
- 肝炎,乙型,慢性 /
- 肝硬化 /
- 基因表达
Abstract: Objective To investigate the expression of cyclooxygenase-2 (COX-2) and CDKN2A in chronic hepatitis B and liver cirrhosis tissues and the relationship between the expression and the liver injury.Methods There were 46 patients with chronic hepatitis B and 17 cases with liver cirrhosis were confirmed through the immunology of liver biopsy;There were 10 normal liver tissues from benign tumors of the liver specimens.Liver inflammation and fibrosis was determined by Pathology.The expression of COX-2 and CDKN2A was determined by immunohisto-chemistry, semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) and Western blot.Results (1) The expression level of the first and second exon of CDKN2A mRNA and the semiquantitative analysis of CDKN2A protein in the normal liver、hepatitis B and cirrhosis were significant (F=28.75, 24.86, 26.43, P=0.036, 0.041, 0.038) . (2) The protein level's expression of COX-2, CDKN2A in normal liver, hepatitis B, cirrhosis was significantly different (χ2=13.48, 15.73, P= 0.042, 0.021) ;The protein level's expression of COX-2, CDKN2A in liver inflammation with different levels was significantly different (χ2=22.45, 23.67, P=0.038, 0.027) ;The protein level's expression of COX-2, CDKN2A in Liver fibrosis with different degrees was significantly different (χ2=24.16, 22.53, P=0.024, 0.037) .Conclusion The expression of COX-2 and CDKN2A was related to the development of process of hepatitis and cirrhosis.The COX-2 and CDKN2A may be used as a good indicator of HBV-related liver disease progress.
- cyclooxygenase 2 /
- cyclin-dependent kinase inhibitor p16 /
- hepatitis B /
- chronic /
- liver cirrhosis

HTML全文

参考文献(16)

[1]Nú?ez Martínez O, Clemente Ricote G, García Monzón C.Role of cyclooxygenase-2 in the pathogenesis of chronic liver diseases[J].Med Clin (Barc) , 2003, 121 (19) :743-748.J Clini Hepatol, March 2011, Vol.27, No.3

[2]Kiwerska K, Rydzanicz M, Kram A, et al.Mutational analysis of CDKN2A gene in a group of 390 larynx cancer patients[J].Mol Biol Rep, 2010, 37 (1) :325-332.

[3]Brock MV, Hooker CM, Ota-Machida E, et al.DNA methylation markers and early recurrence in stage I lung cancer[J].N Engl J Med, 2008, 358 (11) :1118-1128.

[4]Perrone G, Santini D, Vincenzi B, et al.COX-2 expression in DCIS:correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features[J].Histopathology, 2005, 46 (5) :561-568.

[5]中华医学会.病毒性肝炎防冶方案[J].中华肝脏病杂志, 2000, 8 (3) :324-329.

[6]Ishak K, Baptista A, Bianchi L, et al.Histological grading and staging of chronic hepatitis[J].J Hepatol, 1995, 22 (6) :696-699.

[7]Cheng J, Imanishi H, Iijima H, et al.Expression of cyclooxygenase 2 and cytosoli phospholipase A2 in the liver tissue of patients with chronichepatitis and liver cirrhosis[J].Hepatol Res, 2002, 23 (3) :185-195.

[8]Cheng AS, Chan HL, Leung WK, et al.Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma:implication of HBx in upregulation of COX-2[J].Mod Pathol, 2004, 17 (10) :1169-1179.

[9]肖汉龙, 王军, 黄团新.环氧化酶-2与肝癌[J].临床肝胆病杂志, 2007, 23 (2) :158-160.

[10]王洪, 王英民, 张波.乙肝肝硬化患者并发肝癌的危险因素研究[J].临床肝胆病杂志, 2007, 23 (1) :34-35.

[11]Abbaszadegan MR, Moaven O, Sima HR, et al.p16 promoter hypermethylation:a useful serum marker for early detection of gastric cancer[J].World J Gastroenterol, 2008, 14 (13) :2055-2060.

[12]Giefing M, Martin-Subero JI, Kiwerska K, et al.Characterization of homozygous deletions in laryngeal squamous cell carcinoma cell lines[J].Cancer Genet Cytogenet, 2008, 184 (1) :38-43.

[13]李林, 陈晓锐, 宋莎莎, 等.PDCD4基因在过氧化氢诱导喉癌细胞凋亡中的作用[J].中国组织化学与细胞化学杂志, 2010, 19 (1) :72-76.

[14]Mohammed NA, Abd El-Aleem SA, El-Hafiz HA, et al.Distribution of constitutive (COX-1) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis:a possible role for COX-2 in the pathogenesis of liver cirrhosis[J].J Clin Pathol, 2004, 57 (4) :350-354.

[15]Fan JG, Chitturi S.Hepatitis B and fatty liver:causal or coincidenta?[J].J Gastroenterol Hepatol, 2008, 23 (5) :679-681.

[16]Fan JG, Farrell GC.Epidemiology of non-alcoholic fatty liver dusease in China[J].J Hepatol, 2009, 50 (1) :204-210.

施引文献

资源附件(0)

访问统计

本文二维码

计量

文章访问数: 4389
HTML全文浏览量: 13
PDF下载量: 981
被引次数: 0

用微信扫码二维码

分享至好友和朋友圈

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

COX-2、CDKN2A在慢性乙型肝炎、肝硬化肝组织中的表达及意义

计量

The study of the expression of COX-2 and CDKN2A in chronic hepatitis B and liver cirrhosis

计量

目录

留言板

COX-2、CDKN2A在慢性乙型肝炎、肝硬化肝组织中的表达及意义

计量

出版历程

The study of the expression of COX-2 and CDKN2A in chronic hepatitis B and liver cirrhosis

计量

出版历程

目录

关于本刊

投稿指南

在线期刊

肝胆学院

指南共识